KLK3 and prostate carcinoma: Nearly three-quarters of prostate cancer deaths occurred in men with PSA in the top quartile (>1.3 ng/mL in men 50 years old, or PSA > 2.3 ng/mL in men 60 years old at time of blood sample).75